138 related articles for article (PubMed ID: 15770410)
1. Combined effect of an ACE inhibitor, perindopril, and interferon on liver fibrosis markers in patients with chronic hepatitis C.
Yoshiji H; Noguchi R; Fukui H
J Gastroenterol; 2005 Feb; 40(2):215-6. PubMed ID: 15770410
[No Abstract] [Full Text] [Related]
2. Interferon augments the anti-fibrotic activity of an angiotensin-converting enzyme inhibitor in patients with refractory chronic hepatitis C.
Yoshiji H; Noguchi R; Kojima H; Ikenaka Y; Kitade M; Kaji K; Uemura M; Yamao J; Fujimoto M; Yamazaki M; Toyohara M; Mitoro A; Fukui H
World J Gastroenterol; 2006 Nov; 12(42):6786-91. PubMed ID: 17106926
[TBL] [Abstract][Full Text] [Related]
3. Chronic hepatitis C in children is a mild and curable liver disease.
Di Marco V
Dig Liver Dis; 2011 Apr; 43(4):266-7. PubMed ID: 21353653
[No Abstract] [Full Text] [Related]
4. Combination of interferon-beta and angiotensin-converting enzyme inhibitor, perindopril, attenuates the murine liver fibrosis development.
Yoshiji H; Kuriyama S; Noguchi R; Yoshii J; Ikenaka Y; Yanase K; Namisaki T; Kitade M; Yamazaki M; Tsujinoue H; Fukui H
Liver Int; 2005 Feb; 25(1):153-61. PubMed ID: 15698413
[TBL] [Abstract][Full Text] [Related]
5. Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.
Maylin S; Martinot-Peignoux M; Moucari R; Boyer N; Ripault MP; Cazals-Hatem D; Giuily N; Castelnau C; Cardoso AC; Asselah T; Féray C; Nicolas-Chanoine MH; Bedossa P; Marcellin P
Gastroenterology; 2008 Sep; 135(3):821-9. PubMed ID: 18593587
[TBL] [Abstract][Full Text] [Related]
6. Effects of bezafibrate in patients with chronic hepatitis C virus infection: combination with interferon and ribavirin.
Fujita N; Kaito M; Kai M; Sugimoto R; Tanaka H; Horiike S; Konishi M; Iwasa M; Watanabe S; Adachi Y
J Viral Hepat; 2006 Jul; 13(7):441-8. PubMed ID: 16792537
[TBL] [Abstract][Full Text] [Related]
7. [Chronic hepatitis C with normal level of alanine-aminotransferase].
Rossi G
Recenti Prog Med; 2004 Nov; 95(11):509-11. PubMed ID: 15598087
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis C infection and sex hormone levels: effect of disease severity and recombinant interferon-alpha therapy.
Nguyen HV; Mollison LC; Taylor TW; Chubb SA; Yeap BB
Intern Med J; 2006 Jun; 36(6):362-6. PubMed ID: 16732861
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity].
Karpińska E; Wawrzynowicz-Syczewska M; Jurczyk K; Morańska I; Urbanowicz W; Boroń-Kaczmarska A
Wiad Lek; 2005; 58(11-12):616-21. PubMed ID: 16594470
[TBL] [Abstract][Full Text] [Related]
11. SNPs in the promoter region of the osteopontin gene as a marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C.
Naito M; Matsui A; Inao M; Nagoshi S; Nagano M; Ito N; Egashira T; Hashimoto M; Mishiro S; Mochida S; Fujiwara K
J Gastroenterol; 2005 Apr; 40(4):381-8. PubMed ID: 15868370
[TBL] [Abstract][Full Text] [Related]
12. Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy.
El-Zayadi AR; Attia M; Badran HM; El-Tawil A; Zalata K; Barakat E; Selim O; El-Nakeeb A; Saied A
Liver Int; 2005 Aug; 25(4):746-51. PubMed ID: 15998425
[TBL] [Abstract][Full Text] [Related]
13. Presence of hepatitis C virus (HCV)-RNA in peripheral blood mononuclear cells in HCV serum negative patients during interferon and ribavirin therapy.
Januszkiewicz-Lewandowska D; Wysocki J; Pernak M; Nowicka K; Zawada M; Rembowska J; Lewandowski K; Mańkowski P; Nowak J
Jpn J Infect Dis; 2007 Feb; 60(1):29-32. PubMed ID: 17314422
[TBL] [Abstract][Full Text] [Related]
14. Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy.
Taniguchi H; Iwasaki Y; Fujiwara A; Sakaguchi K; Moriya A; Yu PC; Takaki A; Fujioka S; Shimomura H; Shiratori Y
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):281-7. PubMed ID: 16460487
[TBL] [Abstract][Full Text] [Related]
15. The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy.
Kurosaki M; Matsunaga K; Hirayama I; Tanaka T; Sato M; Komatsu N; Umeda N; Hosokawa T; Ueda K; Tsuchiya K; Nakanishi H; Itakura J; Asahina Y; Miyake S; Enomoto N; Izumi N
J Hepatol; 2008 May; 48(5):736-42. PubMed ID: 18329125
[TBL] [Abstract][Full Text] [Related]
16. Clinical features of hepatocellular carcinoma that occur after sustained virological response to interferon for chronic hepatitis C.
Ikeda M; Fujiyama S; Tanaka M; Sata M; Ide T; Yatsuhashi H; Watanabe H
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):122-8. PubMed ID: 16706823
[TBL] [Abstract][Full Text] [Related]
17. Interferon gamma-1b for the treatment of fibrosis in chronic hepatitis C infection.
Muir AJ; Sylvestre PB; Rockey DC
J Viral Hepat; 2006 May; 13(5):322-8. PubMed ID: 16637863
[TBL] [Abstract][Full Text] [Related]
18. Effect of long-term interferon therapy for refractory chronic hepatitis c: preventive effect on hepatocarcinogenesis.
Saito Y; Saito H; Tada S; Nakamoto N; Horikawa H; Kurita S; Kitamura K; Ebinuma H; Ishii H; Hibi T
Hepatogastroenterology; 2005; 52(65):1491-6. PubMed ID: 16201104
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis.
Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933
[TBL] [Abstract][Full Text] [Related]
20. Review article: predicting response in hepatitis C virus therapy.
Mihm U; Herrmann E; Sarrazin C; Zeuzem S
Aliment Pharmacol Ther; 2006 Apr; 23(8):1043-54. PubMed ID: 16611264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
